FI962355A0 - Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen - Google Patents

Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen

Info

Publication number
FI962355A0
FI962355A0 FI962355A FI962355A FI962355A0 FI 962355 A0 FI962355 A0 FI 962355A0 FI 962355 A FI962355 A FI 962355A FI 962355 A FI962355 A FI 962355A FI 962355 A0 FI962355 A0 FI 962355A0
Authority
FI
Finland
Prior art keywords
peptide
drugs
treatment
synthetic peptides
respiratory disease
Prior art date
Application number
FI962355A
Other languages
English (en)
Swedish (sv)
Other versions
FI962355A (fi
Inventor
Tsunetomo Takei
Eiji Ohtsubo
Hirosi Ohkawa
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of FI962355A publication Critical patent/FI962355A/fi
Publication of FI962355A0 publication Critical patent/FI962355A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
FI962355A 1993-12-08 1996-06-06 Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen FI962355A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30765793 1993-12-08
PCT/JP1994/002057 WO1995015980A1 (fr) 1993-12-08 1994-12-07 Nouveau peptide synthetique, tensioactif pulmonaire contenant ledit peptide et remede contre le syndrome de souffrance respiratoire

Publications (2)

Publication Number Publication Date
FI962355A FI962355A (fi) 1996-06-06
FI962355A0 true FI962355A0 (fi) 1996-06-06

Family

ID=17971685

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962355A FI962355A0 (fi) 1993-12-08 1996-06-06 Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen

Country Status (22)

Country Link
US (1) US5827825A (fi)
EP (1) EP0733645B1 (fi)
JP (1) JP3644035B2 (fi)
KR (1) KR100342806B1 (fi)
CN (1) CN1057099C (fi)
AT (1) ATE234865T1 (fi)
AU (1) AU682738B2 (fi)
BG (1) BG62777B1 (fi)
CA (1) CA2178345A1 (fi)
CZ (1) CZ162396A3 (fi)
DE (1) DE69432313T2 (fi)
DK (1) DK0733645T3 (fi)
ES (1) ES2189825T3 (fi)
FI (1) FI962355A0 (fi)
HU (1) HU215933B (fi)
NO (1) NO962403L (fi)
NZ (1) NZ277095A (fi)
PL (1) PL180020B1 (fi)
PT (1) PT733645E (fi)
RO (1) RO118298B1 (fi)
SK (1) SK71496A3 (fi)
WO (1) WO1995015980A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2576895A (en) * 1994-12-07 1996-06-26 Tokyo Tanabe Company Limited Intermediate for producing surfactant peptide
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
JPH11217397A (ja) * 1997-11-27 1999-08-10 Saburo Aimoto ペプチドチオールエステルの製造方法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
BR9906091A (pt) * 1999-12-22 2002-06-04 Conselho Nacional Cnpq Usos de resina de troca aniÈnica (epm-7) como suporte sólido para a sìntese peptìdica e para cromatografia de afinidade
WO2003053455A1 (en) 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
DE602004009710T2 (de) * 2003-12-31 2008-08-07 F. Hoffmann-La Roche Ag Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
US7638493B2 (en) 2004-04-29 2009-12-29 Sannamu Lee Artificial pulmonary surfactant compositions and use of the same
KR100635541B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
AU2006203978B2 (en) 2005-01-06 2011-11-03 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
CA2663795A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
CN101980721B (zh) 2008-04-02 2013-03-13 国立大学法人德岛大学 含有合成肽的抗原药物赋形剂和使用其的粘膜疫苗
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
JP2602968B2 (ja) * 1987-11-04 1997-04-23 カリフォルニア バイオテクノロジー インコーポレイテッド 肺胞の界面活性タンパク類
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
US5827825A (en) 1998-10-27
AU1199295A (en) 1995-06-27
BG100554A (bg) 1996-12-31
NO962403D0 (no) 1996-06-07
DE69432313T2 (de) 2003-10-16
EP0733645A4 (en) 1998-12-09
HU9601563D0 (en) 1996-08-28
KR100342806B1 (ko) 2002-11-29
NO962403L (no) 1996-06-07
SK71496A3 (en) 1996-11-06
PT733645E (pt) 2003-07-31
HUT74880A (en) 1997-02-28
KR960706507A (ko) 1996-12-09
BG62777B1 (bg) 2000-07-31
NZ277095A (en) 1997-09-22
CA2178345A1 (en) 1995-06-15
FI962355A (fi) 1996-06-06
WO1995015980A1 (fr) 1995-06-15
HU215933B (hu) 1999-03-29
DE69432313D1 (de) 2003-04-24
EP0733645B1 (en) 2003-03-19
CN1136813A (zh) 1996-11-27
PL314872A1 (en) 1996-09-30
CZ162396A3 (en) 1996-10-16
RO118298B1 (ro) 2003-04-30
ATE234865T1 (de) 2003-04-15
EP0733645A1 (en) 1996-09-25
JP3644035B2 (ja) 2005-04-27
AU682738B2 (en) 1997-10-16
PL180020B1 (en) 2000-12-29
ES2189825T3 (es) 2003-07-16
CN1057099C (zh) 2000-10-04
DK0733645T3 (da) 2003-07-14

Similar Documents

Publication Publication Date Title
FI962355A0 (fi) Uusia synteettisiä peptidejä, niitä sisältävä keuhkojen pinta-aktiivinen aine ja lääke hengityselinsairausoireyhtymän hoitamiseen
CA2191344A1 (en) Synthetic peptide analogs of lung surfactant protein sp-c
SE8603812D0 (sv) Administration of liposomes to mammals
CY2366B1 (en) Process for the production of powdered pulmonary surfactant preparations.
ATE58474T1 (de) Liposomen aus synthetischen lipiden.
SE8702907L (sv) Stabil farmaceutisk preparation innehallande granulocytkoloniststimulerandefaktor och ett sett att producera densamma
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
DK193887D0 (da) Fysiologisk aktivt peptid
AU5284186A (en) Liposome aerosol compositions
FI903280A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 1-/4,5-dihydroksi-N2-(10,12-dimetyyli-1-oksotetradekyyli)ornitiini/-5-(3-hydroksiglutamiini)-6-(3-hydroksiproliini)ekinokandiini B:n valmistamiseksi
DE68905613T2 (de) Pharmazeutische Zubereitung.
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
JPS649938A (en) Oral ingestive composition